Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Brodalumab in Psoriasis and Psoriatic Arthritis
jRCT2080222380Phase 3
- Sponsor
- Kyowa Kirin
- Start
- Jan 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of brodalumab in plaque psoriasis, psoriatic arthritis (PsA), generalized pustular psoriasis (GPP) and 1 more, sponsored by Kyowa Kirin.
02
Drugs
brodalumab
03
Conditions
plaque psoriasispsoriatic arthritis (PsA)generalized pustular psoriasis (GPP)erythrodermic psoriasis (EP)
Beyond the preview
Go deeper on jRCT2080222380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222380.